Related Experiment Videos
[Relapsing polychondritis. Apropos of 4 cases]
Revue De Laryngologie - Otologie - Rhinologie
|January 1, 1989
Summary
This rare connective tissue disease, polychondritis, affects cartilage, commonly starting in the ears and nose, and can lead to serious complications. Current treatments involve steroids and immunosuppressants, but its exact cause remains unknown.
Area of Science:
- Rheumatology
- Immunology
- Pathology
Background:
- Polychondritis is a rare systemic inflammatory disease affecting connective tissues, particularly cartilage.
- It falls under the broad category of connective tissue diseases and systemic vasculitis.
- Over 350 cases have been documented, highlighting its rarity.
Observation:
- Auricular chondritis (ear cartilage inflammation) is the most common initial symptom and is nearly constant.
- Nasal chondritis can lead to saddle-nose deformity.
- Tracheo-bronchial involvement poses the most severe risk due to potential stenosis.
Findings:
- The disease progresses in bouts, potentially involving rheumatoid, ocular, audio-vestibular, dermatological, and renal systems.
- While an immunologic mechanism is suspected, the precise pathogenesis of polychondritis remains unclear.
- Current treatment strategies rely on systemic corticosteroids, with immunosuppressive agents as a possible adjunct.
Implications:
- Understanding the mysterious pathogenesis is crucial for developing targeted therapies.
- Effective management requires a multidisciplinary approach to address multi-systemic involvement.
- Further research into novel treatments beyond current steroid-based regimens is warranted.